Shell Partners with MRCS and MERCY to support Malaysia’s COVID-19 relief and recovery efforts
Aug 16, 2021
Kuala Lumpur – Shell Malaysia today announced a partnership with the Malaysian Red Crescent Society (MRCS) and MERCY Malaysia to provide critical relief and assistance for vulnerable communities impacted by the COVID-19 outbreak, as well as urgently support the national healthcare system in vaccination and other long-term recovery efforts.
Shell is donating a combined total of approximately RM4.2 million (USD1 million) to MRCS and MERCY Malaysia as part of the Company’s Disaster Relief Donation Plan. This brings the total amount that Shell has spent for COVID-19 related initiatives in Malaysia since the pandemic began to approximately RM8.6 million (USD2 million).
“Ensuring all at-risk and vulnerable are adequately protected against the virus is a humanitarian imperative, since they are less resilient to respond and recover from the pandemic compared to more resourced communities,” said Her Highness Dato’ Seri DiRaja Tan Sri (Dr) Tunku Puteri Intan Safinaz binti Almarhum Sultan Abdul Halim Mu’adzam Shah, National Chairperson of MRCS. “MRCS’ aim is to provide care and relief assistance to at risk and vulnerable communities. Shell’s donation will help the programmes we’ve crafted to really meet our MRCS objectives of leaving no one behind in all our efforts.”
Malaysia is experiencing a recent surge in COVID-19 infections, which continues to add pressure on the national healthcare system. Commenting on this, Datuk Dr Ahmad Faizal Mohd Perdaus, President of MERCY Malaysia said, “The COVID-19 pandemic has provided a steep learning experience for MERCY Malaysia. We are compelled to think outside the box and expand our capacity to create, innovate and evolve as a civil society organisation. With Shell’s donation, MERCY Malaysia will be able to activate our COVID-19 Pandemic Strategic Preparedness and Response Plan which will complement the government’s efforts in mitigating the health crisis nationwide.”
“Shell has been growing together with communities in Malaysia for 130 years and we are committed to help where we can,” said Ivan Tan, Country Chairman of Shell Malaysia. “We hope that our donation will provide support to our healthcare sector and some relief for the less fortunate in our communities. We are grateful for this opportunity to scale up and continue the vital services being offered by the Malaysian Red Crescent Society and MERCY Malaysia to help accelerate our nation’s recovery from this pandemic.”
Shell Malaysia’s latest donation of RM4.2 million to MRCS and MERCY Malaysia will:
- Support medical front-liners to provide care and treatment and effectively manage growing numbers of COVID-19 patients via measures including:
- Mobilizing support from volunteers with clinical experience who can support different phases of the patient care process, including training other staff members and providing remote care, as well as ensuring availability of psychosocial support teams for staff members
- Setting up expanded health facilities for the provision and supplies of medical equipment, drugs, and clinical supplies to respond effectively, including high flow nasal cannula (HFNC) and other consumables such as oxygen tubings, finger probe pulse oxymeter, and provision of FDA approved oxygen generators
- Support national efforts to achieve herd immunity in Malaysia by accelerating vaccination/immunization programmes via measures including:
- Providing ambulances services, sick bay, and other essential support for various PPV vaccination centres nationwide
- Mobilizing volunteer teams to conduct door-to-door vaccinations, focusing on the bedridden, disabled, and sick people who are unable to go to designated centres for their vaccine shots
- Deploying mobile vaccination campaigns for vulnerable and at-risk populations like the undocumented or stateless migrants, homeless, indigenous, and other groups residing in rural areas
- Support community programmes for both immediate relief and building long-term resilience via measures including:
- Providing immediate food aid and care packages to those who have lost their source of income due to the pandemic
- Income-generating projects and skills training for refugees and migrant groups to sell their merchandise either via online marketplace and/or setting up physical shops
- Grants worth up to RM10,000 to support single mothers in earning sustainable income with guidance, training and additional support from volunteers
Shell’s collaboration with MRCS and MERCY Malaysia covers states in Peninsular Malaysia, Sarawak and Sabah. It is undertaken in the spirit of cross-sector collaboration or a “whole-of-society” approach in the fight against COVID-19.
For more information on how Shell is supporting Malaysian communities in responding and recovering from the COVID-19 pandemic, please visit https://www.shell.com.my/covid19.
MERCY handover of medical equipment purchased with support from Shell’s funds to Hospital Ampang, including: 2x ventilator units, 3x HFNC Airvo 2 (respiratory support system) units, 3x PAPR units, 4x vital sign monitor units, and 5x stethoscope units (From Left to Right) Siti Zaleha Binti Abdullah, Senior Officer, Administration, Human Resources & Administration Services (HRAS), MERCY Malaysia; Dr Rosnah Bt Ab Latif, Anesthesiology Expert, Anesthesiology & Emergency Care Department, Hospital Ampang; Dr Dinon Bin Mohd, Medical Officer, Klinik QFFD Ampang, MERCY Malaysia; Dzulkefli Bin Dualan, Assistant Medical Officer, Anesthesiology & Emergency Care Department, Hospital Ampang
(From Left to Right) Puan Suhana Sidik, National Board Member of MRCS; CEO of ProtectHealth Corporation, Dato' Dr Anas Alam Faizli; Director-General of Health, Tan Sri Dato Seri Dr Noor Hisham Abdullah and Tuan Haji Hakim bin Haji Hamzah Secretary-General of MRCS; during a house call to vaccinate bedridden patients part MRCS’s mobile clinic initiative, supported by Shell.
About Shell Malaysia– www.shell.com.my
Shell is a global leader in power, energy, and gas technology and is working to meet increasing energy demand and supply challenges by delivering smarter products and cleaner energy, infrastructure, and by developing new energy sources while addressing the impact on the environment. Malaysia is one of Shell’s heartlands. The history of Royal Dutch Shell in Malaysia started about 130 years ago. Shell currently has a strong market presence in the upstream, gas-to-liquids, downstream and business operations sectors in Malaysia. The company is also driven towards contributing to the local talent pipeline, while playing its part in contributing towards the communities and the society through its various flagship social investment activities.
Country Head of Corporate Relations,
The companies in which Royal Dutch Shell plc directly and indirectly owns investments are separate legal entities. In this press release “Shell”, “Shell Group” and “Group” are sometimes used for convenience where references are made to Royal Dutch Shell plc and its subsidiaries in general. Likewise, the words “we”, “us” and “our” are also used to refer to Royal Dutch Shell plc and its subsidiaries in general or to those who work for them. These terms are also used where no useful purpose is served by identifying the particular entity or entities. ‘‘Subsidiaries’’, “Shell subsidiaries” and “Shell companies” as used in this press release refer to entities over which Royal Dutch Shell plc either directly or indirectly has control. Entities and unincorporated arrangements over which Shell has joint control are generally referred to as “joint ventures” and “joint operations”, respectively. Entities over which Shell has significant influence but neither control nor joint control are referred to as “associates”. The term “Shell interest” is used for convenience to indicate the direct and/or indirect ownership interest held by Shell in an entity or unincorporated joint arrangement, after exclusion of all third-party interest. This press release contains forward-looking statements (within the meaning of the U.S. Private Securities Litigation Reform Act of 1995) concerning the financial condition, results of operations and businesses of Royal Dutch Shell. All statements other than statements of historical fact are, or may be deemed to be, forward-looking statements. Forward-looking statements are statements of future expectations that are based on management’s current expectations and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in these statements. Forward-looking statements include, among other things, statements concerning the potential exposure of Royal Dutch Shell to market risks and statements expressing management’s expectations, beliefs, estimates, forecasts, projections and assumptions. These forward-looking statements are identified by their use of terms and phrases such as “aim”, “ambition”, ‘‘anticipate’’, ‘‘believe’’, ‘‘could’’, ‘‘estimate’’, ‘‘expect’’, ‘‘goals’’, ‘‘intend’’, ‘‘may’’, ‘‘objectives’’, ‘‘outlook’’, ‘‘plan’’, ‘‘probably’’, ‘‘project’’, ‘‘risks’’, “schedule”, ‘‘seek’’, ‘‘should’’, ‘‘target’’, ‘‘will’’ and similar terms and phrases. There are a number of factors that could affect the future operations of Royal Dutch Shell and could cause those results to differ materially from those expressed in the forward-looking statements included in this press release, including (without limitation): (a) price fluctuations in crude oil and natural gas; (b) changes in demand for Shell’s products; (c) currency fluctuations; (d) drilling and production results; (e) reserves estimates; (f) loss of market share and industry competition; (g) environmental and physical risks; (h) risks associated with the identification of suitable potential acquisition properties and targets, and successful negotiation and completion of such transactions; (i) the risk of doing business in developing countries and countries subject to international sanctions; (j) legislative, fiscal and regulatory developments including regulatory measures addressing climate change; (k) economic and financial market conditions in various countries and regions; (l) political risks, including the risks of expropriation and renegotiation of the terms of contracts with governmental entities, delays or advancements in the approval of projects and delays in the reimbursement for shared costs; (m) risks associated with the impact of pandemics, such as the COVID-19 (coronavirus) outbreak; and (n) changes in trading conditions. No assurance is provided that future dividend payments will match or exceed previous dividend payments. All forward-looking statements contained in this press release are expressly qualified in their entirety by the cautionary statements contained or referred to in this section. Readers should not place undue reliance on forward-looking statements. Additional risk factors that may affect future results are contained in Royal Dutch Shell’s Form 20-F for the year ended December 31, 2020 (available at www.shell.com/investor and www.sec.gov). These risk factors also expressly qualify all forward-looking statements contained in this press release and should be considered by the reader. Each forward-looking statement speaks only as of the date of this press release, August 16, 2021. Neither Royal Dutch Shell plc nor any of its subsidiaries undertake any obligation to publicly update or revise any forward-looking statement as a result of new information, future events or other information. In light of these risks, results could differ materially from those stated, implied or inferred from the forward-looking statements contained in this press release. We may have used certain terms, such as resources, in this [report] that the United States Securities and Exchange Commission (SEC) strictly prohibits us from including in our filings with the SEC. Investors are urged to consider closely the disclosure in our Form 20-F, File No 1-32575, available on the SEC website www.sec.gov.